Biden administration to spend $3.2 billion on antiviral pills for Covid

The U.S. is investing $3.2 billion to advance the development of antiviral pills to treat Covid-19 and other viruses that have pandemic potential.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.